Treating Sarcopenia in Older and Oldest Old
The DOI matches its Crossref record.
Abstract
The presence of sarcopenia is not only rapidly rising in geriatric clinical practice and research, but is also becoming a significant concept in numerous medical specialties. This rapidly rising concept has encouraged the need to identify methods for treating sarcopenia. Physical activity measures using resistance training exercise, combined with nutritional interventions (protein and amino acid supplementation) have shown to significantly improve muscle mass and strength in older persons. Moreover, resistance training may improve muscle strength and mass by improving protein synthesis in skeletal muscle cells. Aerobic exercise has also shown to hold beneficial impacts on sarcopenia by improving insulin sensitivity. At the moment, the literature indicates that most significant improvement in sarcopenia is based on exercise programs. Thus, this type of intervention should be implemented in a persistent manner over time in elders, with or at risk of muscle loss. At the same time, physical training exercise should include correcting nutritional deficits with supplementation methods. For example, in older sarcopenic patients with adequate renal function, daily protein intake should be increased to >1. 0 grams of protein per kilogram of body weight. In particular, leucine, - hydroxy β-methylbutyrate (HMB), creatine and some milk-based proteins have been shown to improve skeletal muscle protein balance. In addition, it is also recommended for adjustment of for vitamin D deficiency, if present, considering the crucial role of vitamin D in the skeletal muscle. In this review, we provide evidence regarding the effects of different physical exercise protocols, specific nutritional intervention, and some new metabolic agents (HMB, citrulline malate, ornithine, and others) on clinical outcomes related to sarcopenia in older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
on behalf of the SPRINTT Consortium, Marzetti, E., Calvani, R., Tosato, M., Cesari, M., Di Bari, M., Cherubini, A., Collamati, A., D’Angelo, E., Pahor, M., et al. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0704-5 · Cited by 438
“, testosterone, estrogens, growth hormone, insulin-like growth factor-1) have been described with aging and are associated with declining muscle mass [17].”
BackgroundSelf-citationBowen, T. S., Schuler, G., & Adams, V. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12043 · Cited by 426
Physical activity and exercise as countermeasures to physical frailty and sarcopenia
on behalf of the SPRINTT Consortium, Marzetti, E., Calvani, R., Tosato, M., Cesari, M., Di Bari, M., Cherubini, A., Broccatelli, M., Savera, G., D’Elia, M., et al. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0705-4 · Cited by 362
Self-citationYoshimura, Y., Wakabayashi, H., Yamada, M., Kim, H., Harada, A., & Arai, H. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.03.019 · Cited by 365
Epidemiology of sarcopenia and insight into possible therapeutic targets
Dennison, E. M., Sayer, A. A., & Cooper, C. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.60 · Cited by 294
Metadata
- Authors
- Martone, A., Lattanzio, F., Abbatecola, A., Carpia, D., Tosato, M., Marzetti, E., Calvani, R., Onder, G., & Landi, F.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2015-03-01
- Volume
- 21
- Issue
- 13
- Pages
- 1715-1722
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2146807719
- Cited by
- 78
- References
- 0
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treating Sarcopenia in Older and Oldest Old. https://app.cochat.ai/papers/10.2174/1381612821666150130122032
- The paper
- Martone, A., Lattanzio, F., Abbatecola, A., Carpia, D., Tosato, M., Marzetti, E., Calvani, R., Onder, G., & Landi, F. (2015). Treating Sarcopenia in Older and Oldest Old. Current Pharmaceutical Design. https://doi.org/10.2174/1381612821666150130122032
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.